
Cancer, diabetes drugs under government price control to get costlier, report says
New Delhi: Government-controlled medicines, including that of cancer, diabetes, heart-related concerns and other antibiotics, will soon get costlier, Business Today reported government sources as saying. These medicines are expected to see a
Follow